When a bride-to-be went to purchase her wedding dress, she encountered an unexpected requirement: signing a legal waiver acknowledging that her gown might need alterations due to weight loss from GLP-1 medications.
This development reflects a growing trend in the bridal industry, where salons are adapting their contracts to address the increasing use of weight-loss drugs like semaglutide and tirzepatide among clients. These medications, originally developed for diabetes treatment, have gained widespread use for weight management, leading to significant and rapid body changes that can affect garment fit.
Wedding dress contracts have long been standard practice in bridal salons, outlining details such as dress style, color, size, delivery date, and requested alterations. As noted by Mira Bridal Couture, these documents are essential legal agreements that specify the terms of a custom-made gown, including deposit requirements and alteration policies. Kleinfeld Bridal, for example, requires a 60 percent deposit to place an order, with the balance due upon arrival of the gown from the designer.
The Knot emphasizes that wedding dress contracts are not mere formalities but important legal documents that brides should review carefully. They caution that some contracts may allow designers to make alterations without the bride’s consent, underscoring the need to understand all terms before signing.
Lovella Bridal explains that for special-order wedding dresses — garments made specifically for the bride — payment is typically required when the bride says “yes” to the dress, not after alterations are completed. This is because the gown is being manufactured based on the bride’s measurements at the time of order, and any significant changes afterward may necessitate costly adjustments.
With the rise of GLP-1 receptor agonists, brides may experience substantial weight loss between the time they order their dress and the wedding date. This can result in the need for extensive alterations, which may incur additional fees or, in some cases, require reordering the gown entirely. Salons are now incorporating waivers into their contracts to manage expectations and liability related to such changes.
The MSN report confirms that selling wedding gowns has become more complex due to these new weight-loss drugs, prompting bridal boutiques to update their contractual practices. These legal waivers serve to inform brides that while the salon will accommodate reasonable alterations, significant changes in body size may affect the feasibility, cost, or timeline of dress modifications.
As the use of GLP-1 medications continues to grow, industry experts suggest that bridal salons may need to further refine their policies — potentially offering consultation sessions closer to the wedding date or adjusting alteration packages to accommodate post-order body changes. For now, the inclusion of legal waivers marks a clear shift in how bridal businesses are responding to evolving health trends among their clientele.